While Trump's tariffs could have a broad impact on healthcare prices, it is likely they will not have the devastating result ...

Across healthcare system, stakeholders share blame for high costs. This includes hospitals, drugmakers, insurers and others ...

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...

This led them to the conclusion that antibiotics, antivirals and anti-inflammatory drugs were all associated with reduced ...

A bill to stop Pharmacy Benefit Managers or PBMs from giving pharmacies less money than it costs to fill prescriptions advanced through the Iowa House Commerce Committee Tuesday.

they’re going to pay a different tax on the other end if they do so,” she said. In the near term, Conti said, she’s concerned ...

WHY ARE COSTS DIFFERENT FOR BRAND-NAME DRUGS VS ... The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...